Macquarie Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Macquarie Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,900	Closed	-$328K	–	1674
2015 Q1	$328K	Sell	1,900 -13,100	-87%	-$1.92M	﹤0.01%	1341
2014 Q4	$1.72M	Sell	15,000 -148	-1%	-$17.9K	﹤0.01%	1059
2014 Q3	$2.37M	Hold	15,148	–	–	0.01%	944
2014 Q2	$1.87M	Sell	15,148 -3,512	-19%	-$388K	﹤0.01%	1064
2014 Q1	$1.93M	Sell	18,660 -2,479	-12%	-$254K	﹤0.01%	1021
2013 Q4	$1.9M	Sell	21,139 -6,241	-23%	-$498K	﹤0.01%	1006
2013 Q3	$1.83M	Sell	27,380 -87,502	-76%	-$6.03M	﹤0.01%	978
2013 Q2	$7.6M	Buy	+114,882	New	+$6.57M	0.02%	500

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Macquarie Group's SLXP Position: Q2 2015 in Review

Macquarie Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,900 shares — an estimated $328K sold.

Macquarie Group first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $7.6M in Q2 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Macquarie Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Macquarie Group sold 1,900 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $328K.
Macquarie Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Macquarie Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $7.6M in Q2 2013.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Macquarie Group's 13F filing for Q2 2015, filed 14 Aug 2015.